Technical analysis for shorts & longs Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Technical analysis for shorts & longs

SPY 671.91

0.0%

Nov 14 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Clint E. who wrote (18743)	12/21/1998 7:00:00 AM
From: Henry Niman	Read Replies (1) of 67997

Friday AMGN won its dispute with JNJ over rights to a new and improved EPO (AMGN said it was a new molecule and not covered by the 1985 EPO deal with JNJ). This decision by the arbitration panel isn't appealable and should be a major boost to AMGN's bottom line, which would increase their ability to acquire smaller Biotechs. Today's WSJ discusses the decision and notes that the vote should provide a boost to the entire Biotech sector. Details linked to the Biotech Boom table at biocognizance.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next